ScholarLens Back to search
2004•Critical Care MedicineRequires access

ASSESSING THE OFF-LABEL USE OF RECOMBINANT FACTOR VIIA (RFVIIA)

Robert MacLaren, Laura A. Weber, Helga Brake, Julie L Cerese, MARK J. GARDNER, Mario Tanzi

Open publisher page 1 citations

Abstract

SOCIETY OF CRITICAL CARE MEDICINE 34TH CRITICAL CARE CONGRESS PHOENIX, ARIZONA, USA JANUARY 15-19, 2005: Poster Presentation: Hematology

About this research paper

What this paper is about

SOCIETY OF CRITICAL CARE MEDICINE 34TH CRITICAL CARE CONGRESS PHOENIX, ARIZONA, USA JANUARY 15-19, 2005: Poster Presentation: Hematology

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

SOCIETY OF CRITICAL CARE MEDICINE 34TH CRITICAL CARE CONGRESS PHOENIX, ARIZONA, USA JANUARY 15-19, 2005: Poster Presentation: Hematology

Key concepts: Medicine, Factor VIIa, Recombinant factor VIIa, Intensive care medicine, Presentation (obstetrics), Recombinant DNA, Hematology, Pharmacology

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
ASSESSING THE OFF-LABEL USE OF RECOMBINANT FACTOR VIIA (RFVIIA) — Research Paper | ScholarLens